Growth attenuation
Growth Attenuation
Growth attenuation (pronunciation: /ɡroʊθ ætˌɛn.juˈeɪ.ʃən/) is a medical intervention that involves the use of high-dose estrogen therapy to permanently reduce the adult height of children with severe, lifelong physical and cognitive disabilities. The intervention is controversial and has ethical implications.
Etymology
The term 'growth attenuation' is derived from the English words 'growth', meaning the process of increasing in size, and 'attenuation', which means the reduction of the force, effect, or value of something.
Procedure
The procedure involves the administration of high doses of estrogen to the child. This accelerates the process of bone maturation, causing the growth plates to close prematurely and thus limiting the child's final height. The procedure is usually accompanied by a hysterectomy or gonadectomy to prevent the negative side effects of high-dose estrogen, such as menstruation and breast development.
Ethical Controversy
The use of growth attenuation is controversial due to ethical concerns. Critics argue that the procedure infringes on the child's autonomy and bodily integrity, and that it is performed for the convenience of caregivers rather than for the benefit of the child. Supporters argue that the procedure can improve the quality of life for children with severe disabilities and their families.
Related Terms
External links
- Medical encyclopedia article on Growth attenuation
- Wikipedia's article - Growth attenuation
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski